NFKB1 and cancer: NF-κB activity is associated with chemoresistance in various cancers through the induction of genes involved in the control of survival, proliferation, inflammation, DNA repair, metabolic reprogramming, angiogenesis, drug uptake/inactivation, etc., that reduce the efficacy of conventional therapeutics [186].